The Health Secretary said the jabs were not the only solution to obesity but said they would help increase employment ...

Wes Streeting says he has 'settled with the Chancellor' on NHS budget - but some colleagues have reportedly missed the ...

What this means is that by changing only one hormone, “suddenly you change your entire relationship with food”, says Prof ...

Hims & Hers is revolutionizing healthcare with affordable, convenient telehealth services, leading to a 260% stock increase in the last year. Read more here.

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

DEMAND for fat jabs could overwhelm the NHS, the head of the health service has warned as Sir Keir Starmer piled hopes on using them to get obese jobseekers back to work. Amanda Pritchard, CEO of ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?